Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4357)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 26, 2024 (publication date) through Oct 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cernea S, Onișor D, Roiban AL, Benedek T, Rat N. Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes. World J Cardiol 2024; 16(10): 580-594 [PMID: 39492975 DOI: 10.4330/wjc.v16.i10.580] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i10/580.htm |
| Number | Citing Articles |
| 1 |
Huihui Ren, Mengyuan Hu, Yongli Yan, Mengke Cheng, Chengru Yang, Gang Yuan, Tingting Du. Association of the metabolic dysfunction-associated steatotic liver disease with cardiovascular and kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. Diabetes Research and Clinical Practice 2025; 229: 112927 doi: 10.1016/j.diabres.2025.112927
|
| 2 |
Wei Wang, Charlie Cooper. Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression. World Journal of Cardiology 2025; 17(1): 102467 doi: 10.4330/wjc.v17.i1.102467
|
| 3 |
Jiayang Lin, Ruxin Chen, Junlin Huang, Yating Liu, Chensihan Huang, Yan Huang, Bingyan Xu, Yunqian Li, Xinyu He, Hongzhen Lv, Xueyun Wei, Peizhen Zhang, Dan Guo, Jinhua Zhang, Huijie Zhang. MASLD-related fibrosis, but not MASLD, is associated with left ventricular concentric hypertrophy in patients with type 2 diabetes. Journal of Endocrinological Investigation 2025; doi: 10.1007/s40618-025-02682-6
|
| 4 |
Elena-Daniela Grigorescu, Bogdan-Mircea Mihai, Georgiana-Diana Cazac-Panaite, Adina-Bianca Foșălău, Alina Onofriescu, Mariana Floria, Cristina Gena Dascălu, Alexandr Ceasovschih, Laurențiu Șorodoc, Cristina-Mihaela Lăcătușu. Age-Related Characteristics of Diastolic Dysfunction in Type 2 Diabetes Patients. Journal of Clinical Medicine 2025; 14(16): 5772 doi: 10.3390/jcm14165772
|
| 5 |
Danusia Onișor, Andrada Larisa Roiban, Simona Cernea. Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators. Medicina 2024; 60(12): 2091 doi: 10.3390/medicina60122091
|
| 6 |
Simona Cernea, Andrada Larisa Roiban, Danusia Onișor. Hyperferritinemia and the Risk of Liver Fibrosis and Liver-Related Events in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease. Medicina 2025; 61(9): 1518 doi: 10.3390/medicina61091518
|
| 7 |
Simona Cernea, Andrada Larisa Roiban, Danusia Onișor, Nora Rat. Epicardial Adipose Tissue and Liver Fibrosis in Patients With Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Liver Disease. Reviews in Cardiovascular Medicine 2025; 26(8) doi: 10.31083/RCM39534
|
| 8 |
Simona Cernea, Danusia Onișor, Andrada Larisa Roiban. The impact of the Mediterranean diet on liver steatosis and fibrosis in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease. Acta Marisiensis - Seria Medica 2025; 71(3): 188 doi: 10.2478/amma-2025-0030
|
| 9 |
Panagiotis Theofilis, Konstantinos Tsioufis, Dimitris Tousoulis. Response to the Letter to the Editor: Epicardial Adipose Tissue Modulation: A New Horizon for Sodium-glucose Cotransporter 2 Inhibitors. Current Vascular Pharmacology 2025; 23(4): 233 doi: 10.2174/0115701611401801250512101055
|